首頁 > 市場調查報告書 > 材料

包裝/容器

市場調查報告書

商品編碼

1465582

空膠囊市場規模- 按類型（明膠、素食膠囊）、來源（豬明膠、牛源明膠、骨粉、澱粉材料和普魯蘭多醣）、功能、膠囊尺寸、應用、最終用戶和全球預測，2024 - 2032年

Empty Capsules Market Size - By Type (Gelatin, Vegetarian Capsules), Source (Porcine Gelatin, Bovine Derived Gelatin, Bone Meal, Starch Materials & Pullulan), Functionality, Capsule Size, Application, End-user & Global Forecast, 2024 - 2032

出版日期: 2024年02月29日 | 出版商:

Global Market Insights Inc. | 英文 224 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

由於膠囊製造技術的不斷進步以及人們對明膠和非明膠膠囊的日益青睞，全球空膠囊市場規模在 2024 年至 2032 年間將呈現 7.7% 的複合年成長率。這些進步提高了膠囊的品質、穩定性以及與各種配方的兼容性。明膠膠囊在製藥和營養保健品領域仍然很受歡迎，而 HPMC 和普魯蘭多醣等非明膠膠囊則迎合了素食主義者和純素食主義者的偏好。這種技術創新和多樣化膠囊偏好的雙重趨勢將推動空心膠囊行業向前發展。

例如，2023 年 2 月，Operio 集團旗下品牌、全球配料解決方案提供商 Vivion, Inc. 推出了一系列新的 HPMC、空明膠和支鏈澱粉膠囊。

空膠囊產業根據類型、來源、功能、膠囊尺寸、應用、最終用戶和地區而分散。

由於全球膳食補充劑和功能性食品的需求不斷成長，到 2032 年，營養保健品產業將建立顯著的市場立足點。空膠囊為營養保健品提供了一種方便且可客製化的輸送方式，吸引了尋求健康和保健解決方案的消費者。隨著對天然成分和健康趨勢的關注，營養保健品產業將推動對空膠囊的需求。

由於牛源明膠在藥品、營養保健品和膳食補充劑中的廣泛應用，從 2024 年到 2032 年，其空膠囊市場佔有率將顯著上升。牛明膠膠囊具有出色的穩定性和與多種配方的相容性，使其成為製造商的首選。隨著製藥業對明膠膠囊的需求不斷成長以及營養保健品的日益普及，牛源明膠領域將保持其在空心膠囊市場的主導地位。

在製藥和營養保健品產業不斷擴張的推動下，尤其是在中國和印度等國家，亞太空心膠囊市場將在 2024 年至 2032 年間實現顯著的複合年成長率。醫療保健支出的增加和人口老化的加劇也增加了對空膠囊的需求。隨著研發投資的增加，亞太地區將成為市場擴張的關鍵貢獻者，在藥物傳輸和膳食補充劑領域提供廣泛的應用。

產業生態系統分析
產業影響力
- 成長動力
  - 空心膠囊的技術進步
  - 全球心血管疾病等慢性病盛行率不斷上升
  - 增加膳食補充劑和維生素的攝取量
- 產業陷阱與挑戰
  - 原物料價格波動
  - 文化習俗和飲食限制
成長潛力分析
監管環境
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司矩陣分析
競爭定位矩陣
戰略儀錶板

第 5 章：市場估計與預測：按類型，2018 - 2032

主要趨勢
明膠膠囊
- 硬膠囊
- 軟膠囊
素食膠囊

第 6 章：市場估計與預測：按來源分類，2018 年 - 2032 年

主要趨勢
豬明膠
牛源明膠
骨粉
羥丙基甲基纖維素（HPMC）
澱粉原料及普魯蘭多醣

第 7 章：市場估計與預測：按功能分類，2018 年 - 2032 年

主要趨勢
立即發布
持續釋放
延遲發布

第 8 章：市場估計與預測：按膠囊類型，2018 年 - 2032 年

主要趨勢
尺寸“000
尺寸“00”
尺寸“0”
尺寸“1”
尺寸“2”
尺寸“3”
尺寸“4”
尺寸“5”

第 9 章：市場估計與預測：按應用分類，2018 年 - 2032 年

主要趨勢
抗生素和抗菌藥物
維生素和膳食補充劑
制酸劑和抗氣脹製劑
心血管治療藥物
其他治療應用

第 10 章：市場估計與預測：按最終用戶分類，2018 年 - 2032 年

主要趨勢
醫藥行業
保健品業
化妝品產業
研究實驗室

第 11 章：市場估計與預測：按地區分類，2018 年 - 2032 年

主要動向：按地區
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 中東和非洲其他地區

第 12 章：公司簡介

ACG
Bright Pharma Caps Inc.
CapsCanada Corporation
Erawat Pharma Limited
HealthCaps India
Lonza Group
Medi-Caps Ltd.
Mitsubishi Chemical Holdings Corporation
Nectar Lifesciences Ltd.
Qingdao Yiqing Biotechnology Co., Ltd.
Seoheung Co., Ltd.

簡介目錄

Product Code: 8344

Global Empty Capsules Market size will exhibit a 7.7% CAGR between 2024 and 2032, owing to ongoing advancements in capsule manufacturing technologies in line with the increasing preference for both gelatin and non-gelatin capsules. These advancements improve capsule quality, stability, and compatibility with various formulations. Gelatin-based capsules remain popular in the pharmaceutical and nutraceutical sectors, while non-gelatin options like HPMC and pullulan cater to vegetarian and vegan preferences. This dual trend of technological innovation and diverse capsule preferences will propel the empty capsules industry forward.

For instance, in February 2023, Vivion, Inc., a brand of Operio Group and a global ingredient solutions provider, launched a new range of HPMC, empty gelatin, and pullulan capsules.

The empty capsules industry is fragmented based on type, source, functionality, capsule size, application, end-user, and region.

The nutraceuticals industry segment will establish a notable market foothold by 2032, attributed to the increasing demand for dietary supplements and functional foods worldwide. Empty capsules provide a convenient and customizable delivery method for nutraceutical products, appealing to consumers seeking health and wellness solutions. With a focus on natural ingredients and wellness trends, the nutraceuticals industry will drive demand for empty capsules.

The empty capsules market share from the bovine-derived gelatin segment will record a significant uptick from 2024 to 2032 due to its widespread use in pharmaceuticals, nutraceuticals, and dietary supplements. Bovine gelatin capsules offer excellent stability and compatibility with a variety of formulations, making them a preferred choice for manufacturers. With a rising demand for gelatin-based capsules in the pharmaceutical industry and the increasing popularity of nutraceuticals, the bovine-derived gelatin segment will maintain its dominance in the empty capsules market.

Asia Pacific empty capsules market will secure a noteworthy CAGR between 2024 and 2032, driven by expanding pharmaceutical and nutraceutical industries, especially in countries like China and India. Rising healthcare expenditures and a growing aging population also contribute to the demand for empty capsules. With increasing investments in research and development, Asia Pacific will emerge as a key contributor to the market's expansion, offering a wide range of applications in drug delivery and dietary supplements.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Technological advancements in empty capsules
  - 3.2.1.2 Growing prevalence of chronic ailments such as cardiovascular diseases worldwide
  - 3.2.1.3 Increasing intake of dietary supplements and vitamins
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Fluctuating raw material prices
  - 3.2.2.2 Cultural practices and dietary restrictions
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
- 3.5.1 Supplier power
- 3.5.2 Buyer power
- 3.5.3 Threat of new entrants
- 3.5.4 Threat of substitutes
- 3.5.5 Industry rivalry
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive positioning matrix
4.4 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2018 - 2032 ($ Million)

5.1 Key trends
5.2 Gelatin based capsules
- 5.2.1 Hard capsules
- 5.2.2 Soft capsules
5.3 Vegetarian capsules

Chapter 6 Market Estimates and Forecast, By Source, 2018 - 2032 ($ Million)

6.1 Key trends
6.2 Porcine gelatin
6.3 Bovine derived gelatin
6.4 Bone meal
6.5 Hydroxy propyl methyl cellulose (HPMC)
6.6 Starch materials & pullulan

Chapter 7 Market Estimates and Forecast, By Functionality, 2018 - 2032 ($ Million)

7.1 Key trends
7.2 Immediate release
7.3 Sustained release
7.4 Delayed release

Chapter 8 Market Estimates and Forecast, By Capsule Type, 2018 - 2032 ($ Million)

8.1 Key trends
8.2 Size "000
8.3 Size "00"
8.4 Size "0"
8.5 Size "1"
8.6 Size "2"
8.7 Size "3"
8.8 Size "4"
8.9 Size "5"

Chapter 9 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Million)

9.1 Key trends
9.2 Antibiotic and antibacterial drugs
9.3 Vitamins and dietary supplements
9.4 Antacid and antiflatulent preparations
9.5 Cardiovascular therapy drugs
9.6 Other therapeutic applications

Chapter 10 Market Estimates and Forecast, By End-User, 2018 - 2032 ($ Million)

10.1 Key trends
10.2 Pharmaceuticals industry
10.3 Nutraceuticals industry
10.4 Cosmetics industry
10.5 Research laboratories

Chapter 11 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Million)

11.1 Key trends, by region
11.2 North America
- 11.2.1 U.S.
- 11.2.2 Canada
11.3 Europe
- 11.3.1 Germany
- 11.3.2 UK
- 11.3.3 France
- 11.3.4 Italy
- 11.3.5 Spain
- 11.3.6 Rest of Europe
11.4 Asia Pacific
- 11.4.1 China
- 11.4.2 Japan
- 11.4.3 India
- 11.4.4 Australia
- 11.4.5 South Korea
- 11.4.6 Rest of Asia Pacific
11.5 Latin America
- 11.5.1 Brazil
- 11.5.2 Mexico
- 11.5.3 Rest of Latin America
11.6 Middle East and Africa
- 11.6.1 South Africa
- 11.6.2 Saudi Arabia
- 11.6.3 Rest of Middle East and Africa